Compare LAND & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LAND | EBS |
|---|---|---|
| Founded | 1997 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 361.5M | 303.3M |
| IPO Year | 2010 | 2006 |
| Metric | LAND | EBS |
|---|---|---|
| Price | $6.83 | $5.78 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 3 |
| Target Price | $9.00 | ★ $10.00 |
| AVG Volume (30 Days) | 1.0M | ★ 1.1M |
| Earning Date | 11-10-2026 | 11-02-2026 |
| Dividend Yield | ★ 7.98% | N/A |
| EPS Growth | N/A | ★ 125.83 |
| EPS | ★ N/A | N/A |
| Revenue | $88,339,000.00 | ★ $742,900,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $7.66 | $7.03 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 3.66 | N/A |
| 52 Week Low | $6.70 | $4.36 |
| 52 Week High | $13.00 | $14.06 |
| Indicator | LAND | EBS |
|---|---|---|
| Relative Strength Index (RSI) | 25.90 | 38.19 |
| Support Level | N/A | $5.51 |
| Resistance Level | $9.83 | $6.83 |
| Average True Range (ATR) | 0.40 | 0.45 |
| MACD | -0.05 | -0.06 |
| Stochastic Oscillator | 11.02 | 15.04 |
Gladstone Land Corp is an externally-managed, agricultural REIT. It is mainly in the business of owning and leasing farmland. It manages operations in one reporting segment: Real Estate Rental Operations. It is focused on the ownership of farms and farm-related properties that are leased on a triple-net basis to tenants with a good operating history and deep farming resources. The farmland is predominantly concentrated in locations where farmers are able to grow either fresh produce or annual row crops (e.g., certain berries and vegetables), which are typically planted and harvested annually, or certain permanent crops (e.g., almonds, blueberries, pistachios, and wine grapes). To a much lesser extent, it also owns farms that grow certain commodity crops (e.g., corn and beans).
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. Geographically, the company operates in United States, Canada, and Others. It derives maximum revenue from United states. The company's products include: NARCAN Nasal Spray, KLOXXADO Nasal Spray, ACAM2000, ANTHRASIL, BAT, BioThrax, CNJ-016, raxibacumab injection, Ebanga, and others.